Fluxion Biosciences Inc.
South San Francisco, CA · Medtech · Private
Microfluidic devices that mimic the pulmonary microvasculature to produce platelets in vitro from megakaryocytes
fluxionbio.com →- Grants
- $1.6M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $1.5M
- 20 awards · Defense, Veterans Affairs, Health and Human S
- #251 of 4531 in medtech
- Patents
- 12
- 3 granted · 9 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20082010201220142016201820202022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · Shear Flow Assay System | $46,330 | |
| Federal contract | Department of Defense · Bioflux Wpm 48-WELL Plates | $22,470 | |
| Federal contract | Department of Defense · Shear Flow Assay System | $41,000 | |
| Federal contract | Department of Defense · Fluxion Bioflux 1000 | $162,550 | |
| Federal contract | Department of Veterans Affairs · Procurement Of Medical Lab Equipment | $245,000 | |
| Federal contract | Department of Defense · 930-0069 Cfi Plan | $16,550 | |
| Federal contract | Department of Defense · 1000 Wpm 48 Well Plates 0-20 Dynes, | $10,700 | |
| Federal contract | Department of Defense · Annual Service Plan For Bioflux 1000Z | $30,600 | |
| Federal contract | Department of Veterans Affairs · Bioflux 200 Shear Flow Assay System For Live Cell Imaging | $29,950 | |
| Federal contract | Department of Defense · 48 Well Plates 0-20 DYN/CM2, , Bio Flux | $7,499 | |
| Federal contract | Department of Defense · Well Plates, Bioflux 1000 Wpm, | $8,858 | |
| Federal contract | Department of Veterans Affairs · Research Equipment | $245,895 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf Biofluxion 1000Z | $27,375 | |
| Federal contract | Department of Defense · Bioflux 1000 Wpm 48 Well Plates 020 | $24,050 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf Preventative Annual Maintenance For Bioflux Equipment | $148,505 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · ERASE-Seq, an ultra-sensitive variant caller for liquid biopsy applications | $300,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · ERASE-Seq, an ultra-sensitive variant caller for liquid biopsy applications | $355,000 | |
| Federal grant | Department of Health and Human Services · Phase I · A novel NIPT assay based on single cell sequencing | $284,132 | |
| Federal grant | Department of Health and Human Services · Phase I · ERASE-Seq, an ultra-sensitive variant caller for liquid biopsy applications | $55,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Platelet Production in a Pulmonary-based Microfluidic Reactor | $308,559 | |
| Federal grant | Department of Health and Human Services · Phase I · Platelet Production in a Pulmonary-based Microfluidic Reactor | $308,559 | |
| Federal contract | Department of Health and Human Services · Laboratory Equipment | $148,545 | |
| Federal contract | Department of Health and Human Services · Procurement Of A Fluxion Bioflux 200 Microfluidic Device System In Support Of The National Institutes Of Health (NIH), National Cancer Institute (nci), Center For Cancer Research (ccr), Laboratory Of Molecular Biology (lmb) | $53,803 | |
| Federal contract | Department of Health and Human Services · Recombinant Cell Line | $126,312 | |
| Federal contract | Department of Health and Human Services · Ion Flux Upgrade | $110,000 | |
| Federal contract | Department of Veterans Affairs · Pm Of Bio Fluxion Equipment | $34,150 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 248 | IMAGINAB, INC. | $1.6M | $36M |
| 249 | Pulmonx Corp | $1.6M | $170M |
| 250 | IMPULSE TECHNOLOGY LLC | $1.5M | $300K |
| 251 | Fluxion Biosciences Inc. | $1.5M | — |
| 252 | PRAEVIUM RESEARCH INC | $1.5M | — |
| 253 | SAGE SCIENCE, INC. | $1.5M | $9.9M |
| 254 | Ekso Bionics, Inc. | $1.5M | $14M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Molecular Characterization Of Single Cells And Cell Populations For Non-invasive Diagnosticsgranted
- Methods and Systems for Ultra-Sensitive Detection of Genomic Alterationsgranted
- Molecular Characterization Of Single Cells and Cell Populations For Non-Invasive Diagnosticsgranted
- Methods And Systems For Cell Separation Using Magnetic-and Size-based Separationapplication
- Methods And Apparatus For The Manipulation Of Particle Suspensions And Testing Thereofapplication
- Molecular Characterization Of Single Cells And Cell Populations For Non-invasive Diagnosticsapplication
- Methods And Systems For Ultra-sensitive Detection Of Genomic Alterationsapplication
- Methods And Systems For Cell Separation Using Magnetic-and Size-based Separationapplication
- Molecular Characterization of Single Cells and Cell Populationsapplication
- Multiparametric Methods And Systems For Cell Separation Including Diagnostic Applicationsapplication
- Devices, Systems, And Methods For Magnetic Separationapplication
- Methods And Apparatus For The Manipulation Of Particle Suspensions And Testing Thereofapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.